Section of Experimental Medicine, School of Pharmacy, University of Camerino Camerino, Italy.
Front Immunol. 2013 Feb 14;4:34. doi: 10.3389/fimmu.2013.00034. eCollection 2013.
The transient receptor potential vanilloid type-2 (TRPV2), belonging to the transient receptor potential channel family, is a specialized ion channel expressed in human and other mammalian immune cells. This channel has been found to be expressed in CD34(+) hematopoietic stem cells, where its cytosolic Ca(2) (+) activity is crucial for stem/progenitor cell cycle progression, growth, and differentiation. In innate immune cells, TRPV2 is expressed in granulocytes, macrophages, and monocytes where it stimulates fMet-Leu-Phe migration, zymosan-, immunoglobulin G-, and complement-mediated phagocytosis, and lipopolysaccharide-induced tumor necrosis factor-alpha and interleukin-6 production. In mast cells, activation of TRPV2 allows intracellular Ca(2) (+) ions flux, thus stimulating protein kinase A-dependent degranulation. In addition, TRPV2 is highly expressed in CD56(+) natural killer cells. TRPV2 orchestrates Ca(2) (+) signal in T cell activation, proliferation, and effector functions. Moreover, messenger RNA for TRPV2 are expressed in CD4(+) and CD8(+) T lymphocytes. Finally, TRPV2 is expressed in CD19(+) B lymphocytes where it regulates Ca(2) (+) release during B cell development and activation. Overall, the specific expression of TRPV2 in immune cells suggests a role in immune-mediated diseases and offers new potential targets for immunomodulation.
瞬时受体电位香草酸型 2 通道(TRPV2)属于瞬时受体电位通道家族,是一种在人类和其他哺乳动物免疫细胞中表达的特殊离子通道。该通道已被发现在 CD34(+)造血干细胞中表达,其细胞质 Ca(2) (+)活性对干细胞/祖细胞周期进程、生长和分化至关重要。在先天免疫细胞中,TRPV2 表达在粒细胞、巨噬细胞和单核细胞中,它刺激 fMet-Leu-Phe 迁移、zymosan、免疫球蛋白 G 和补体介导的吞噬作用,以及脂多糖诱导的肿瘤坏死因子-α和白细胞介素-6 的产生。在肥大细胞中,TRPV2 的激活允许细胞内 Ca(2) (+)离子流,从而刺激蛋白激酶 A 依赖性脱颗粒。此外,TRPV2 在 CD56(+)自然杀伤细胞中高度表达。TRPV2 在 T 细胞激活、增殖和效应功能中协调 Ca(2) (+)信号。此外,TRPV2 的信使 RNA 在 CD4(+)和 CD8(+)T 淋巴细胞中表达。最后,TRPV2 在 CD19(+)B 淋巴细胞中表达,它调节 B 细胞发育和激活过程中的 Ca(2) (+)释放。总的来说,TRPV2 在免疫细胞中的特异性表达表明其在免疫介导的疾病中具有作用,并为免疫调节提供了新的潜在靶点。